Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis Post author:Sam Post published:October 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Mauna Kea Technologies: Cellvizio Now CE Marked For Use During Robotic-Assisted Surgery October 9, 2017 Lexicon Pharma Secures Up to $200M Non-Dilutive Term Loan Financing December 4, 2017 How Bristol-Myers Squibb Went From Potential Mega-Acquirer to Vulnerable Mega-Target January 26, 2017
Mauna Kea Technologies: Cellvizio Now CE Marked For Use During Robotic-Assisted Surgery October 9, 2017
How Bristol-Myers Squibb Went From Potential Mega-Acquirer to Vulnerable Mega-Target January 26, 2017